Imaging-defined residual risk after left atrial appendage occlusion: from device surveillance to antithrombotic and reintervention decision considerations - Report - MDSpire

Imaging-defined residual risk after left atrial appendage occlusion: from device surveillance to antithrombotic and reintervention decision considerations

  • By

  • Yuan Li

  • Yujian Liu

  • July 9, 2026

  • 0 min

Share

Clinical Report: Residual Risk Assessment via Imaging Following LAAO

Overview

This review discusses post-left atrial appendage occlusion (LAAO) imaging findings and their implications. It emphasizes the need for a risk-weighted interpretation of imaging results.

Background

Left atrial appendage occlusion (LAAO) is increasingly utilized for stroke prevention in patients with nonvalvular atrial fibrillation, particularly when long-term anticoagulation is not feasible. Despite favorable procedural outcomes, post-implantation imaging findings can create uncertainty regarding residual thromboembolic risk.

Data Highlights

No numerical data or trial data presented in the source material.

Key Findings

  • Device-related thrombus (DRT) occurs at a rate of approximately 6.3 per 100 patient-years compared to 1.7 per 100 patient-years in those without DRT.
  • Hypoattenuated thickening (HAT) presents a range of imaging phenotypes, from expected healing to thrombus-like abnormalities.
  • Cardiac computed tomography angiography (CCTA) detects residual appendage patency and peri-device leak (PDL) more frequently than transesophageal echocardiography (TEE).
  • Post-LAAO imaging findings can be categorized into three domains: device surface abnormality, residual communication, and device-appendage geometry.
  • Most management implications are based on expert consensus and observational data rather than prospective trials.

Clinical Implications

Clinicians should consider the implications of imaging-defined residual risks when making decisions about antithrombotic therapy and device monitoring.

Conclusion

The review highlights the importance of integrating imaging findings into clinical decision pathways for patients post-LAAO.

Related Resources & Content

  1. Frontiers in Cardiovascular Medicine, 2026 -- Right atrial appendage thrombosis after percutaneous left atrial appendage occlusion: a case report
  2. Frontiers in Cardiovascular Medicine, 2026 -- Optimizing left atrial appendage imaging: the diagnostic value of left lateral decubitus cardiac CT angiography
  3. Clinical Research in Cardiology, 2025 -- Evaluation of Treatment Approaches for Atrial Fibrillation Patients with Left Atrial Appendage Thrombus Despite Optimal NOAC Management
  4. 2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion
  5. Meta-Analysis: LAA Patency Associated With Increased Thromboembolic Risk - American College of Cardiology
  6. Clinical Research in Cardiology (Springer) — Comparison of therapeutic strategies in patients presenting with left atrial thrombus despite oral anticoagulation
  7. 2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion
  8. Meta-Analysis: LAA Patency Associated With Increased Thromboembolic Risk - American College of Cardiology
  9. Outcomes of Left Atrial Appendage Occlusion With a Coated Device: Primary Analysis of HEAL-LAA - PubMed

Original Source(s)

Related Content